Showing results (151-160 of 361) with videos related to

Sort By:
Pageof 37
Biorxiv : the Preprint Server for Biology|February 9, 2026
Keratin 5 marks cancer-propagating cells sustained by an osteopontin-producing niche in high-grade serous ovarian carcinomaMallikarjun Bidarimath, Coulter Q Ralston, Nandini Bidarimath, et al.
Gynecologic Oncology|March 19, 2011
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignanciesLydia Usha, Michael W Sill, Kathleen M Darcy, et al.
Gynecologic Oncology|July 15, 2011
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group studyKian Behbakht, Michael W Sill, Kathleen M Darcy, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|March 19, 2008
Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasiaCarolyn Y Fang, Suzanne M Miller, Dana H Bovbjerg, et al.
Scientific Reports|December 8, 2017
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa studyKishore Polireddy, Ruochen Dong, Gregory Reed, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 21, 2007
Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancerRobert E Page, Andrés J P Klein-Szanto, Samuel Litwin, et al.
Gynecologic Oncology|January 24, 2009
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rashRussell J Schilder, Harsh B Pathak, Anna E Lokshin, et al.
Molecular and Cellular Biology|June 30, 2016
Follicle Depletion Provides a Permissive Environment for Ovarian CarcinogenesisYing Wang, Kathy Qi Cai, Elizabeth R Smith, et al.
Molecular Cancer Therapeutics|August 13, 2009
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumorLori Rink, Yuliya Skorobogatko, Andrew V Kossenkov, et al.
International Journal of Molecular Sciences|May 28, 2022
Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine SignalRishi Man Chugh, Payel Bhanja, Ximena Diaz Olea, et al.
Pageof 37